Xinwei Medical

Xinwei Medical, founded in Shanghai in 2016, is a leading Chinese developer of neurointerventional medical devices focused on the treatment and prevention of strokes. The company has commercialized four NMPA-approved ischemic stroke treatment instruments forming a complete stent thrombectomy suite. Its pipeline includes over twenty products spanning acute ischemic/hemo­rrhagic strokes to interventional access tools. Xinwei’s sirolimus drug-eluting balloon catheter for intracranial stenosis represents a global first-in-class innovation expected to launch soon. The firm’s sales network covers all provinces of mainland China except Hong Kong/Macau/Taiwan, with ambitions to expand further into cardiac/pulmonary intervention fields.